These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years. Buch P, Rasmussen S, Abildstrom SZ, Køber L, Carlsen J, Torp-Pedersen C, TRACE investigators. Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070 [Abstract] [Full Text] [Related]
5. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study. Gustafsson F, Køber L, Torp-Pedersen C, Per Hildebrandt. J Hypertens Suppl; 1998 Jan; 16(1):S65-70. PubMed ID: 9534100 [Abstract] [Full Text] [Related]
6. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us? Reynolds G, Hall AS, Ball SG. Eur J Clin Pharmacol; 1996 Jan; 49 Suppl 1():S35-9. PubMed ID: 8834930 [Abstract] [Full Text] [Related]
8. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure. Abildstrom SZ, Ottesen MM, Rask-Madsen C, Andersen PK, Rosthøj S, Torp-Pedersen C, Køber L. Int J Cardiol; 2005 Sep 30; 104(2):184-9. PubMed ID: 16168812 [Abstract] [Full Text] [Related]
9. [ACE inhibitors in the treatment of patients with acute myocardial infarct]. Borghi C, Ambrosioni E. Ann Ital Med Int; 1995 Sep 30; 10(3):175-87. PubMed ID: 7577315 [Abstract] [Full Text] [Related]